United Kingdom · Question · Written question
HL HL16242
Rare Cancers
Introduced
13 April 2026
Last action
15 April 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 April 2026
Summary
To ask His Majesty's Government, in relation to proposed appointment of a national lead for rare cancers, what is the expected term length of the appointment in months; what are the proposed the contract start and end dates; and what are the details of an
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 April 2026
Written question
To ask His Majesty's Government, in relation to proposed appointment of a national lead for rare cancers, what is the expected term length of the appointment in months; what are the proposed the contract start and end dates; and what are the details of an
Source: Lords
15 April 2026
Answer
The National Cancer Plan, published on 4 February 2026, sets out several commitments and ambitions, to be delivered within the next 10 years.This includes appointing a national clinical lead for rare cancers, to sit on the National Cancer Board and advise...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-04-13/HL16242
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1898946
- uk · wq-1898946 · source updated 15 April 2026